ArticleJournal of diabetes investigation2026
Five-year follow-up of incretin-based therapy in a patient with KCNJ11-related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction.
Toshiaki Ohkuma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.